Theraclion
Robotic focused-ultrasound systems for non-invasive treatment of varicose veins, thyroid nodules and breast fibroadenoma
Highlights
- New on EvolcAdded 2026-10-31
About Theraclion
Theraclion develops robotic medical devices for non-invasive focused-ultrasound treatment. Its SONOVEIN platform treats varicose veins, while ECHOPULSE treats thyroid nodules and breast fibroadenoma.
The systems are designed for healthcare providers, including treatment in a physician’s office. The company is based in Malakoff, France, and was founded in 2004.
Product: Robotic focused-ultrasound medical devices for treating varicose veins, thyroid nodules and breast fibroadenoma.
Jobs at Theraclion
No open positions listed right now.
Leadership
- Martin Deterre · Chief Executive OfficerSource: company website
- Julie Veisseire · Chief Financial OfficerSource: company website
More health & medtech companies
Therapanacea
AI software for radiotherapy planning and adaptive treatment workflows, built with clinicians for cancer centres and hospitalsNew on EvolcTherapixel
Imaging AI software that helps radiologists detect breast cancer in mammography screeningNew on EvolcTheremia
AI models for optimising drug dosing and formulation in neurology and psychiatry, sold to biotech drug developersYoung companyNew on EvolcTherenva
AI-based endovascular planning and C-arm image fusion software for interventional cardiologists and vascular surgeonsNew on EvolcTheryq
Radiotherapy machines with linear accelerators, using FLASH technology, for cancer treatment centresNew on EvolcThinkin Tech
Wearable ultrasound guidance devices for aesthetic practitioners performing dermal filler injectionsYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Bootstrap
- Google Tag Manager
- WordPress
- jQuery